Marimed (MRMD) Amortization of Deferred Charges (2024 - 2026)

Marimed (MRMD) has reported Amortization of Deferred Charges for 3 consecutive years, with $19000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 5.56% year-over-year to $19000.0 in Q2 2026; TTM through Jun 2026 was $74000.0, a 2.78% increase from a year earlier, with the FY2025 full-year figure at $73000.0, changed 0.0% from the prior year.
• Amortization of Deferred Charges was $19000.0 for Q2 2026 at Marimed, up from $18000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $19000.0 in Q4 2025 and troughed at $18000.0 in Q1 2024.
• A 3-year average of $18200.0 and a median of $18000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
• The widest YoY moves for Amortization of Deferred Charges: up 5.56% in 2025, down 0.0% in 2025.
• Over 3 years, Amortization of Deferred Charges stood at $18000.0 in 2024, then grew by 5.56% to $19000.0 in 2025, then changed by 0.0% to $19000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $19000.0 (Q2 2026), $18000.0 (Q1 2026), and $19000.0 (Q4 2025), per Business Quant data.